Price
No data yet.
Social Signal Score
Analyst Ratings
36 analystsRevenue
$2.98B+12.51%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Andrew Hider
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Employees
- 37,500
- Beta
- 0.67
- Country
- US
- Piotroski score
- 4 / 9 (Middling)
- Altman Z-score
- 2.45
Financials
Revenue
$2.98B+12.5%Net Income
$294.00M+21.0%EBITDA
$478.00M-4.4%Free Cash Flow
$448.00M-12.7%EPS (diluted)
$0.57+29.5%Shares Outstanding (diluted)
520.00M-5.6%Operating Expenses
$855.00MCash & Debt
$1.98BReturn of Capital
$5.00MRevenue by Segment (annual)
$10.86BDividend per Share
$0.01Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $11.24B | $-957.00M | $-1.75 |
| 2024 | $10.64B | $-649.00M | $-1.27 |
| 2023 | $10.36B | $2.66B | $5.25 |
| 2022 | $10.06B | $-2.43B | $-4.83 |
| 2021 | $12.15B | $1.28B | $2.56 |
| 2020 | $11.67B | $1.10B | $2.17 |
| 2019 | $11.36B | $1.00B | $1.97 |
| 2018 | $11.10B | $1.55B | $3.04 |
| 2017 | $10.58B | $602.00M | $1.11 |
| 2016 | $10.16B | $4.96B | $9.09 |
| 2015 | $9.97B | $968.00M | $1.78 |
| 2014 | $10.72B | $2.50B | $4.61 |
| 2013 | $9.41B | $2.01B | $3.70 |
| 2012 | $13.94B | $2.33B | $4.22 |
Valuation
BAXhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
60-14.29%Social Signal Score
Mentions (19)
- Newsfool.com·4d ago·Positive
Baxter: 3 Key Takeaways for Long-Term Investors Third-quarter global sales reached $3 billion, up 5% organically. Year-to-date free cash flow exceeded $700 million.
View source ↗ - News (RSS)zerohedge·17d ago·Negative
Going Postal On The GOP? Kansas Mail Carrier Charged With Stealing Thousands Of Letters Going Postal On The GOP? Kansas Mail Carrier Charged With Stealing Thousands Of Letters A federal grand jury in Wichita indicted a rural route carrier on Election Day for stealing 4,404 pieces of mail, nearly 400 of them political mailers that were all for Republican candidates or Republican-affiliated PACs, according to a release from the U.S. Attorney's Office for the District of Kansas.Kelly R. Cram, 59, o
View source ↗ - Newsmarketbeat.com·23d ago·Positive
What Baxter International (BAX) Said on Its Q3 Earnings Call Baxter International NYSE: BAX raised its full-year 2026 outlook after reporting third-quarter sales and adjusted earnings that exceeded its expectations, citing broad-based growth across its portfolio, improving execution and strong free cash flow generation.
View source ↗ - News (RSS)seekingalpha·24d ago·Positive
Baxter falls despite double beat, boosting guidance
View source ↗ - Newszacks.com·24d ago·Positive
Baxter Q3 Earnings Beat on Broad-Based Growth, '26 Outlook Raised BAX beats Q3 earnings and revenue estimates, driven by broad-based segment growth, and raises its 2026 outlook despite continued margin pressure.
View source ↗ - Newsseekingalpha.com·24d ago·Positive
Baxter International Inc. (BAX) Q3 2026 Earnings Call Transcript Baxter International Inc. (BAX) Q3 2026 Earnings Call Transcript
View source ↗ - Newszacks.com·24d ago·Positive
Baxter International (BAX) Q3 Earnings and Revenues Surpass Estimates Baxter International (BAX) came out with quarterly earnings of $0.58 per share, beating the Zacks Consensus Estimate of $0.51 per share. This compares to earnings of $0.69 per share a year ago.
View source ↗ - Newszacks.com·27d ago·Positive
Will Baxter's Q3 Earnings Show Progress Despite Cost Pressures? Baxter International Inc. BAX is scheduled to release third-quarter 2026 results on Oct. 29, before the opening bell. In the last reported quarter, the company's earnings beat the Zacks Consensus Estimate by 55.6%.
View source ↗ - Newsseekingalpha.com·40d ago·Negative
Baxter International: The Vantive Transition Complicates Margin Recovery Baxter International is rated Hold, with a $25 target price and limited 2.6% upside, reflecting muted near-term margin recovery. Revenue growth is supported by Advanced Surgery and compounding, but infusion solutions face structural headwinds, and Novum IQ LVP supply issues persist. Margins lag revenue growth; cost reductions and inventory normalization may help, but transition expenses and debt reduction remain priorities …
View source ↗ - Newsbusinesswire.com·46d ago·Neutral
Baxter to Host Third-Quarter 2026 Financial Results Conference Call for Investors DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its third-quarter 2026 financial results on Thursday, October 29, 2026, at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://events.q4inc.com/analyst/129835310?pwd=2FG2j7ZZ to pre-register for the call and receive the call information.Th…
View source ↗ - Newszacks.com·47d ago·Positive
Are Investors Undervaluing Baxter International (BAX) Right Now? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
View source ↗ - Newszacks.com·47d ago·Negative
Is Baxter International (BAX) Stock Outpacing Its Medical Peers This Year? Here is how Baxter International (BAX) and Bayer Aktiengesellschaft (BAYRY) have performed compared to their sector so far this year.
View source ↗ - News (Marketaux)gurufocus.com·48d ago·Positive
BAX Maintained by Citigroup -- Price Target Lowered to $27.00 Baxter International B[+320 characters]
View source ↗ - Newszacks.com·59d ago·Neutral
Here's Why You Should Retain Baxter Stock in Your Portfolio for Now BAX's portfolio reset and growth in connected care and advanced surgery support prospects, but margins, Novum IQ and China pricing remain risks.
View source ↗ - Newsseekingalpha.com·74d ago·Positive
Baxter International Inc. (BAX) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript Baxter International Inc. (BAX) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
View source ↗ - Newszacks.com·76d ago·Positive
BAX Raises 2026 Outlook as Strong Q2 Growth Offsets Margin Pressure Baxter raises its 2026 sales and earnings outlook after strong Q2 growth, though manufacturing costs, tariffs and pricing pressure margins.
View source ↗ - Newsdefenseworld.net·92d ago·Negative
Baxter Bros Inc. Invests $12.20 Million in GE Vernova Inc. $GEV Baxter Bros Inc. purchased a new stake in GE Vernova Inc. (NYSE: GEV) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 10,385 shares of the company's stock, valued at approximately $12,201,000. GE Vernova accounts for 1.4% of
View source ↗ - Newsbusinesswire.com·96d ago·Negative
Baxter Announces Pricing for Its Upsized Cash Tender Offers DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) (“Baxter” or the “Company”) today announced the pricing terms for its previously announced cash tender offers (each, an “Offer” and collectively, the “Offers”) of the Company's validly tendered (and not validly withdrawn) notes set forth below (the “Notes”) using a “waterfall” methodology under which the Company will accept the Notes in order of their respective acce…
View source ↗ - News (Marketaux)acquirersmultiple.com·97d ago·Positive
Rich Pzena’s Latest Portfolio: Top 10 Holdings & Biggest Moves Portfolio Snapshot Total Portfolio Valu[+358 characters]
View source ↗
Earnings
Thu, Feb 11(in 3 months)
Consensus estimate $0.60 per share
Typical surprise +13.8% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Oct 29$0.58 vs $0.52beat
- Thu, Jul 30$0.56 vs $0.37beat
- Thu, Apr 30$0.36 vs $0.31beat
- Thu, Feb 12$0.44 vs $0.53miss
- Thu, Oct 30$0.69 vs $0.60beat
- Thu, Jul 31$0.59 vs $0.60miss
Estimates and results for BAX via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by BAX officers and directors.
No open-market trades in the recent filings. All 100 recent Form 4 entries were share awards, option exercises or tax withholding — pay, not decisions to buy or sell.
100 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- Ro Khannahouse · CA17 · disclosed Jun 11, 2026 (41d later)Buy$1,001 - $15,000
- Michael T. McCaulhouse · TX10 · disclosed Apr 10, 2026 (18d later)Buy$15,001 - $50,000
- Michael T. McCaulhouse · TX10 · disclosed Feb 12, 2026 (30d later)Buy$50,001 - $100,000
- Lisa C. McClainhouse · MI09 · disclosed Nov 24, 2025 (24d later)Sell$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Nov 24, 2025 (25d later)Buy$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Nov 24, 2025 (25d later)Sell$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Oct 22, 2025 (27d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Oct 3, 2025 (28d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Oct 3, 2025 (4d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Oct 3, 2025 (30d later)Sell$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Sep 15, 2025 (42d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Sep 12, 2025 (17d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Sep 12, 2025 (31d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Sep 12, 2025 (39d later)Buy$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Aug 13, 2025 (22d later)Buy$1,001 - $15,000
- Robert P. Bresnahanhouse · PA08 · disclosed Jun 10, 2025 (26d later)Buy$1,001 - $15,000
- Earl Blumenauerhouse · OR03 · disclosed Aug 6, 2024 (28d later)Buy$15,001 - $50,000
- Ro Khannahouse · CA17 · disclosed Feb 5, 2024 (28d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Feb 5, 2024 (28d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Nov 8, 2023 (22d later)Buy$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
